|
Bravecto
|
250 mg
|
EU/2/13/158/021
|
Intervet International B.V., Nīderlande
|
QP53B
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Fluralaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet UK Ltd, Lielbritānija
|
| Date of authorisation/renewal: |
13-Feb-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/13/158/021 |
250 mg |
2 |
Pipete, 1 deva |
-
|
|
|
Profender tablets for large dogs
|
-
|
EU/2/05/054/029
|
Vetoquinol S.A., Francija
|
QP52AA51
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
modified-release tablets
|
| International name (active substance): |
Praziquantel,Emodepside
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
KVP Pharma + Veterinar Produkte GmbH, Vācija
|
| Date of authorisation/renewal: |
29-Jul-2010
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/05/054/029 |
150 mg/30 mg |
4 |
Alumīnija blisteris, 1 tablete |
-
|
|
|
NASYM
|
-
|
EU/2/19/241/003
|
Laboratorios Hipra S.A., Spānija
|
QI02AD04
|
cattle
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
Lyophilisate and solvent for suspension for injection or nasal spray
|
| International name (active substance): |
Live attenuated bovine respiratory syncytial virus, strain Lym-56
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Laboratorios Hipra S.A., Spānija
|
| Date of authorisation/renewal: |
29-Jul-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/241/003 |
|
10 |
Stikla flakons, 5 devas/flakonā |
-
|
|
|
Clomicalm 80 mg
|
80 mg
|
EU/2/98/007/003
|
VIRBAC, Francija
|
QN06AA04
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Clomipramine hydrochloride
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Elanco France S.A.S., Francija
|
| Date of authorisation/renewal: |
10-Apr-2008
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/98/007/003 |
80 mg |
1 |
ABPE pudele, 30 tablete |
-
|
|
|
MHYOSPHERE PCV ID
|
0.2 ml
|
EU/2/20/259/001
|
Laboratorios Hipra S.A., Spānija
|
QI09AL08
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Inactivated recombinant Mycoplasma hyopneumoniaecpPCV2, strain Nexhyon, Mycoplasma hyopneumoniae, Porcine circovirus type 2 (PCV2) capsid protein
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Laboratorios Hipra S.A., Spānija
|
| Date of authorisation/renewal: |
18-Sep-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/20/259/001 |
|
1 |
PET flakons, 50 devas/flakonā |
-
|
|
|
Emepax 60 mg
|
60 mg
|
EU/2/26/363/010
|
Axience, Francija
|
QA04AD90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Maropitant citrate monohydrate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Lelypharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
26-Mar-2026
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/26/363/010 |
|
10 |
OPA/Al/PVH-Al blisteris, 4 tablete |
-
|
|
|
APOQUEL
|
3.6 mg
|
EU/2/13/154/034
|
Zoetis Belgium S.A., Beļģija
|
QD11AH90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
Chewable tablet
|
| International name (active substance): |
Oclacitinib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Belgium S.A., Beļģija
|
| Date of authorisation/renewal: |
04-Jul-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/13/154/034 |
3,6 mg |
5 |
Blisteris, 10 tablete |
-
|
|
|
Suvaxyn Circo
|
-
|
EU/2/17/223/004
|
Zoetis Belgium S.A., Beļģija
|
QI09AA
|
fattening pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Inactivated porcine circovirus with type 2 ORF2 protein
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
07-Feb-2018
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/17/223/004 |
25 deva |
10 |
Polietilēna flakons, 50 ml |
-
|
|
|
ZULVAC 8 Ovis
|
-
|
EU/2/09/104/001
|
Zoetis Belgium S.A., Beļģija
|
QI02AA02
|
sheep
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Bluetongue virus serotype 8 antigen
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Manufacturing & Research Spain S.L., Spānija
|
| Date of authorisation/renewal: |
14-Jan-2015
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/09/104/001 |
|
1 |
Stikla flakons, 50 deva |
-
|
|
|
Coxatab
|
25 mg
|
EU/2/22/286/002
|
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
QM01AH90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
Chewable tablet
|
| International name (active substance): |
Firocoxib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
| Date of authorisation/renewal: |
12-Aug-2022
|
| Marketing authorisation valid until: |
11-Aug-2027
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/22/286/002 |
25 mg/tabl. |
1 |
alumīnija/PVC/PE/PVDC blisteris, 20 tablete |
-
|
|
|
Bovilis Cryptium
|
-
|
EU/2/23/303/001
|
Intervet International B.V., Nīderlande
|
QI02AO02
|
Cattle (pregnant heifer); Cattle (pregnant cow)
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Cryptosporidium parvum, glycoprotein gp40
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
23-Nov-2023
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/23/303/001 |
|
10 |
Stikla flakons, 2 ml/deva |
-
|
|
|
Advocate Spot-on šķīdums gigantiskiem suņiem
|
-
|
EU/2/03/039/011
|
Bayer Animal Health , Vācija
|
QP54AB52
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Moxidectin,Imidacloprid
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
KVP Pharma + Veterinar Produkte GmbH, Vācija
|
| Date of authorisation/renewal: |
01-Apr-2003
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/03/039/011 |
|
3 |
Pipete, 4 ml |
-
|
|
|
Hyogen
|
-
|
V/I/19/0048
|
Ceva Sante Animale', Francija
|
QI09AB13
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Inactivated Mycoplasma hyopneumoniae, strain 2940
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
|
| Date of authorisation/renewal: |
18-Sep-2024
|
| Marketing authorisation valid until: |
17-Sep-2029
|
| Marketing authorisation procedure: |
I
|
| Package leaflet: |
[DOCX] 26082025LI (26-Aug-2025)
|
| Labelling text: |
See products section
|
| Summary of product characteristics: |
-
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/I/19/0048-02 |
|
5 |
PET pudele, 50 deva |
[PDF]
[PDF]
[PDF]
|
|
|
Equilis Prequenza Te
|
-
|
EU/2/05/057/003
|
Intervet International B.V., Nīderlande
|
QI05AL01
|
horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
A/equine-2/Newmarket/1/93,A/equine-2/Newmarket/2/93,A/equine-1/Praque/1/56,Purified haemagglutinin subunits from equine influenza viruses: A/equine-1/Praque/1/56
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet International Booxmer, Nīderlande
|
| Date of authorisation/renewal: |
10-Aug-2006
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/05/057/003 |
|
1 |
Pilnšļirce, 1 deva |
-
|
|
|
Felpreva
|
-
|
EU/2/21/277/002
|
Vetoquinol S.A., Francija
|
QP52AA51
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Tigolaner, Emodepside, Praziquantel
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Vetoquinol S.A., Francija
|
| Date of authorisation/renewal: |
11-Nov-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/21/277/002 |
|
2 |
Polipropilēna aplikators, 0,37 ml |
-
|
|
|
Nobilis IB 4 - 91
|
-
|
EU/2/98/006/010
|
Intervet International Booxmer, Nīderlande
|
QI01AD07
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate for suspension
|
| International name (active substance): |
Live attenuated Infectious Bronchitis virus
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
21-May-2008
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/98/006/010 |
|
10 |
Stikla flakons, 500 deva |
-
|
|
|
Intramar LC
|
-
|
V/I/24/0067
|
Bioveta, a.s., Čehija
|
QJ51RV01
|
cattle
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
intramammary suspension
|
| International name (active substance): |
Amoxicillin trihydrate, Potassium clavulanate, Prednisolone
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Bioveta, a.s., Čehija
|
| Date of authorisation/renewal: |
16-Oct-2024
|
| Marketing authorisation valid until: |
15-Oct-2029
|
| Marketing authorisation procedure: |
I
|
| Package leaflet: |
[DOCX] 16102024LI (16-Oct-2024)
|
| Labelling text: |
See products section
|
| Summary of product characteristics: |
-
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/I/24/0067-01 |
|
24 |
Injektors, 4 g |
[PDF]
|
|
|
Librela
|
20 mg
|
EU/2/20/261/012
|
Zoetis Belgium S.A., Beļģija
|
QN02BG91
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Bedinvetmab
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Belgium S.A., Beļģija
|
| Date of authorisation/renewal: |
10-Nov-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/20/261/012 |
20 mg |
6 |
Stikla flakons, 1 ml |
-
|
|
|
Onsior
|
40 mg
|
EU/2/08/089/028
|
Elanco GmbH, Vācija
|
QM01AH91
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Robenacoxib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Elanco France S.A.S, Francija;Vericore Ltd., Lielbritānija
|
| Date of authorisation/renewal: |
16-Dec-2008
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/08/089/028 |
40 mg/tabl. |
30 |
Alumīnija blisteris, 1 tablete |
-
|
|
|
Simparica
|
40 mg/tabl.
|
EU/2/15/191/011
|
Zoetis Belgium S.A., Beļģija
|
QP53BE03
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Sarolaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Belgium S.A., Beļģija
|
| Date of authorisation/renewal: |
12-Aug-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/15/191/011 |
|
1 |
Al/Al blisteris, 3 tablete |
-
|
|